Clinical Trial Update: A Study Of Daratumumab, Low-Dose Oral Dexamethasone and Cyclophosphamide With Or Without Pomalidomide [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating daratumumab with low-dose dexamethasone and cyclophosphamide, with or without pomalidomide, in relapsed or refractory multiple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Daratumumab (daratumumab)
• Low-Dose Oral Dexamethasone (dexamethasone)
• Pomalidomide (Pomalidomide)

Snippet

Sponsor: Canadian Myeloma Research Group | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED